Organization type


  • Academic research institution

Screening


  • Chemical libraries
    • Natural product extracts: plants, microbial, animal (invertebrates, insects)
    • Small molecules (including natural product, DNA encoded libraries and fragment libraries)
  • Fragment based screening
    • Hit expansion. Medicinal chemistry programs.
    • Virtual screening

Optimization phases


  • Medicinal chemistry programs for hit to lead and lead optimization
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
    • ADME / DMPK
    • Safety
    • Toxicology

Functional areas


  • Artificial intelligence
  • Bioinformatics
  • Structural biology

Terapeutic areas


  • Autoimmunity / Inflammation
  • Blood and lymphatic system
  • Cancer
  • Cardiovascular
  • Dermatology
  • Infectious diseases
  • Metabolism / Endocrinology
  • Nervous Central System
  • Ophthalmology / Optometry
  • Rare diseases

Additional activities


  • Government initiatives supporting drug and research collaborations
  • Industry associations